This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Daiichi Sankyo Co., Ltd.
Drug Names(s): U31784, U3 1784
U3-1784 is a human monoclonal antibody specifically raised against the Fibroblast Growth Factor Receptor 4 (FGFR4).
Partners: BioInvent International AB
Pink Sheet FDA Recalls For Nov. 12, 2014
Additional information available to subscribers only: